These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35310041)

  • 1. PTPN18 Stimulates the Development of Ovarian Cancer by Activating the PI3K/AKT Signaling.
    Mao N; Li H; Yang H; Su J; Liang Z; He G
    Evid Based Complement Alternat Med; 2022; 2022():1091042. PubMed ID: 35310041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of PTPN18 for regulating the migration and invasion of endometrial cancer cells via the MYC/PI3K/AKT pathway.
    Suo S; Chen S; Zhou L; Xu R; Li J; Li W
    Histol Histopathol; 2024 May; ():18767. PubMed ID: 38855855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of PTPN18 can inhibit proliferation and metastasis and promote apoptosis of endometrial cancer.
    Cai J; Huang S; Yi Y; Bao S
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):734-742. PubMed ID: 31034093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: PTPN18 Stimulates the Development of Ovarian Cancer by Activating the PI3K/AKT Signaling.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9846528. PubMed ID: 37501832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN18 promotes colorectal cancer progression by regulating the c-MYC-CDK4 axis.
    Li C; Li SZ; Huang XC; Chen J; Liu W; Zhang XD; Song XM; Du RL
    Genes Dis; 2021 Nov; 8(6):838-848. PubMed ID: 34522712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of PTPN18 Induced Ferroptosis in Endometrial Cancer Cells Through p-P38-Mediated GPX4/xCT Down-Regulation.
    Wang H; Peng S; Cai J; Bao S
    Cancer Manag Res; 2021; 13():1757-1765. PubMed ID: 33642877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2.
    Wang T; Ba X; Zhang X; Zhang N; Wang G; Bai B; Li T; Zhao J; Zhao Y; Yu Y; Wang B
    Cell Death Dis; 2022 Aug; 13(8):720. PubMed ID: 35982039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
    Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
    Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway.
    Zhang LQ; Yang HQ; Yang SQ; Wang Y; Chen XJ; Lu HS; Zhao LP
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819874773. PubMed ID: 31537175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway.
    Wang Y; Luo X; Wu N; Liao Q; Wang J
    Med Oncol; 2023 Jan; 40(2):76. PubMed ID: 36625999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ca
    Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
    Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes.
    Wang HM; Xu YF; Ning SL; Yang DX; Li Y; Du YJ; Yang F; Zhang Y; Liang N; Yao W; Zhang LL; Gu LC; Gao CJ; Pang Q; Chen YX; Xiao KH; Ma R; Yu X; Sun JP
    Cell Res; 2014 Sep; 24(9):1067-90. PubMed ID: 25081058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling.
    Hao Q; Gao L; Niu W; Chen L; Zhang P; Chen Z
    Biofactors; 2020 Jul; 46(4):685-692. PubMed ID: 32589786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Per2 overexpression on growth inhibition and metastasis, and on MTA1, nm23-H1 and the autophagy-associated PI3K/PKB signaling pathway in nude mice xenograft models of ovarian cancer.
    Wang Z; Li L; Wang Y
    Mol Med Rep; 2016 Jun; 13(6):4561-8. PubMed ID: 27082164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
    Wang Z; Liu C
    PLoS One; 2021; 16(4):e0250603. PubMed ID: 33901239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
    Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
    Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.
    Zhang J; Liu XH; Li C; Wu XX; Chen YL; Li WW; Li X; Gong F; Tang Q; Jiang D
    J Exp Clin Cancer Res; 2020 May; 39(1):79. PubMed ID: 32381034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.